Vedanta Biosciences has received a research grant from CARB-X to support the development of an anti-infective to treat hospital-acquired infections by multi-drug resistant organisms (MDRO).
Cipla USA has announced the acquisition of the prescription drug ZEMDRI (Plazomicin) from Achaogen in a Chapter 11, U.S. Bankruptcy Code auction of Achaogen’s assets.